CLARKSON JOHN G 4
4 · NOVEN PHARMACEUTICALS INC · Filed Aug 27, 2009
Insider Transaction Report
Form 4
CLARKSON JOHN G
Director
Transactions
- Disposition to Issuer
Common Stock ($.0001 par value)
2009-08-27$16.50/sh−9,120$150,480→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2009-08-27−7,500→ 0 totalExercise: $18.73Exp: 2014-05-17→ (Common Stock ($.0001 par value) (7,500 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2009-08-27−7,500→ 0 totalExercise: $17.41Exp: 2015-05-23→ (Common Stock ($.0001 par value) (7,500 underlying)
Footnotes (1)
- [F1]Represents stock options cancelled at the Effective Time (as defined in the Merger Agreement), pursuant to the terms of an Agreement and Plan of Merger among the Issuer, Hisamitsu Pharmaceutical Co., Inc. ("Hisamitsu") and certain subsidiaries of Hisamitsu, dated as of July 14, 2009 (the "Merger Agreement"). The reporting person did not receive any cash payment therefor as the exercise price exceeded the tender offer price of $16.50 per share.